Journal
BRITISH JOURNAL OF CANCER
Volume 93, Issue 2, Pages 173-177Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6602698
Keywords
docetaxel; taxotere; taxanes; pharmacology
Categories
Ask authors/readers for more resources
Since the introduction of docetaxel, research has focused on various approaches to overcome treatment limitations and improve outcome. This review discusses the pharmacological attempts at treatment optimisation, which include reducing interindividual pharmacokinetic and pharmacodynamic variability, optimising schedule, route of administration, reversing drug resistance and the development of structurally related second-generation taxanes. (c) 2005 Cancer Research UK.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available